142 related articles for article (PubMed ID: 34100060)
1. Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers.
Eggers KM; Lindhagen L; Lindhagen L; Baron T; Erlinge D; Hjort M; Jernberg T; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):806-812. PubMed ID: 34100060
[TBL] [Abstract][Full Text] [Related]
2. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
[TBL] [Abstract][Full Text] [Related]
3. Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry.
Eggers KM; Lindhagen L; Baron T; Erlinge D; Hjort M; Jernberg T; Johnston N; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
PLoS One; 2021; 16(4):e0249830. PubMed ID: 33831096
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide molecular forms for risk stratification and prediction of outcome after acute myocardial infarction.
Israr MZ; Heaney LM; Ng LL; Suzuki T
Am Heart J; 2018 Jun; 200():37-43. PubMed ID: 29898847
[TBL] [Abstract][Full Text] [Related]
5. Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
Ferreira JP; Sharma A; Mehta C; Bakris G; Rossignol P; White WB; Zannad F
Clin Res Cardiol; 2021 Jul; 110(7):1006-1019. PubMed ID: 32789678
[TBL] [Abstract][Full Text] [Related]
6. Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction.
Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mörtberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallén HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
J Intern Med; 2020 Nov; 288(5):581-592. PubMed ID: 32638487
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
8. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A
PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866
[TBL] [Abstract][Full Text] [Related]
9. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
Sabatine MS; Morrow DA; de Lemos JA; Gibson CM; Murphy SA; Rifai N; McCabe C; Antman EM; Cannon CP; Braunwald E
Circulation; 2002 Apr; 105(15):1760-3. PubMed ID: 11956114
[TBL] [Abstract][Full Text] [Related]
10. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
11. Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.
Hjort M; Eggers KM; Lindhagen L; Agewall S; Brolin EB; Collste O; Daniel M; Ekenbäck C; Frick M; Henareh L; Hofman-Bang C; Malmqvist K; Spaak J; Sörensson P; Y-Hassan S; Tornvall P; Lindahl B
Clin Chem; 2019 Aug; 65(8):1023-1030. PubMed ID: 31072836
[TBL] [Abstract][Full Text] [Related]
12. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
13. Correlation between Troponin-I and B-Type Natriuretic Peptide Level in Acute Myocardial Infarction Patients with Heart Failure.
Islam MN; Alam MF; Debnath RC; Aditya GP; Ali MH; Hossain MA; Siddique SR
Mymensingh Med J; 2016 Apr; 25(2):226-31. PubMed ID: 27277352
[TBL] [Abstract][Full Text] [Related]
14. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.
Palmer BR; Pilbrow AP; Yandle TG; Frampton CM; Richards AM; Nicholls MG; Cameron VA
J Am Coll Cardiol; 2003 Mar; 41(5):729-36. PubMed ID: 12628714
[TBL] [Abstract][Full Text] [Related]
16. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
18. Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance.
Shindo K; Fukuda H; Hitsumoto T; Ito S; Kim J; Washio T; Kitakaze M
Cardiovasc Drugs Ther; 2020 Feb; 34(1):79-88. PubMed ID: 32076931
[TBL] [Abstract][Full Text] [Related]
19. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
20. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
